Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Revenue From Contract With Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Immune Medicine revenue
Service revenue	$	6,559	$	8,169	$	20,968	$	17,622
Collaboration revenue		21,320		15,446		50,105		49,137
Total Immune Medicine revenue		27,879		23,615		71,073		66,759
MRD revenue
Service revenue		19,951		14,352		55,037		39,655
Regulatory milestone revenue		—		1,500		4,000		10,000
Total MRD revenue		19,951		15,852		59,037		49,655
Total revenue	$	47,830	$	39,467	$	130,110	$	116,414